Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Experimental and Therapeutic Medicine
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-0981 Online ISSN: 1792-1015
Journal Cover
May-2017 Volume 13 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
May-2017 Volume 13 Issue 5

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway

  • Authors:
    • Lei Zhu
    • Weihua Li
    • Gongjian Qi
    • Na Liu
    • Liping Sheng
    • Lei Shang
    • Boxiang Qi
  • View Affiliations / Copyright

    Affiliations: Department of Intensive Care Unit, Xuzhou Children's Hospital, Xuzhou, Jiangsu 221006, P.R. China
    Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 2263-2266
    |
    Published online on: March 20, 2017
       https://doi.org/10.3892/etm.2017.4245
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Immunological response is thought to play a crucial role in the development of a severe hand-foot-and-mouth disease (HFMD) infection in children, but the mechanisms remain largely unknown. This study was designed to help in elucidating the immunopathological pathways involved in the disease by quantifying Toll-like receptor (TLR) mRNAs, MAPK factors and cytokine levels in children experiencing the disease. A total of 86 enterovirus 71 (EV71)‑infected HFMD children (49 with mild and 27 with severe disease), along with 30 healthy children were involved in the study. Peripheral vein blood samples were collected from each individual, and used to isolate peripheral blood mononuclear cells (PBMCs) for mRNA extraction and sera for measuring levels of tumor necrosis factor (TNF)‑α, interferon (IFN)‑γ, interleukin (IL)‑6 and IL‑10. The average expression levels of TLR3, TLR4, TLR7 and TLR8 mRNA in PBMCs of children with severe HFMD were significantly higher than those in the other children, the lowest values were found in the healthy control group (P<0.05). The expression levels of TLR2 and TLR9 mRNA were not significantly different (P>0.05) among the groups. Additionally, the expression levels of TNF‑α, IFN‑γ, IL‑6 and IL‑10 in the serum of the children in the severe group were significantly higher than those in the other two groups, and the lowest values were again found in the control group (P<0.05). Pearson correlation analysis showed that the TLR3, TLR4, TLR7 and TLR8 mRNA levels in PBMCs were positively correlated with the TNF-α, IFN-γ, IL‑6 and IL‑10 levels in the serum (P<0.05). Furthermore, the expression levels of the ERK, JNK and p38 mRNA in PBMCs of children in the severe group were significantly higher than those in the other two groups, with the lowest values being in the control group (P<0.05). Pearson correlation analysis showed that the TLR3, TLR4, TLR7 and TLR8 mRNA levels in PBMCs were positively correlated with ERK, JNK and p38 mRNA levels (P<0.05). The results of our study seem to indicate that the high expression levels of TLR3, TLR4, TLR7 and TLR8 induced in severe EV71 HFMD regulate the expression of cytokines by MAPK signaling pathway and negatively affect the ability of the organism to resolve the infection. Further studies are needed to test the hypothesis that immuno-modulation would be an effective treatment approach in pediatric cases of severe HFMD.

Introduction

Hand-foot-and-mouth disease (HFMD) is an acute infectious disease with high incidence in preschool children, caused by a variety of enterovirus infections, and the clinical symptoms include fever, rash and sores on a plurality of sites of the hands, feet and mouth (1). Enterovirus 71 (EV71) and Coxsackie virus A16 are common etiological agents of HFMD, among which, EV71 can cause severe central nervous system damage and multiple-organ dysfunction and even become life threatening (2). EV71 infection can cause immune system dysfunction; T lymphocyte subsets can secrete a variety of inflammatory cytokines, which can worsen the disease symptoms (3).

Toll-like receptors (TLRs) are important pattern recognition molecules; those associated with the viral infection include TLR2, 3, 4, 7, 8 and 9 (4,5). After recognizing the virus, TLRs can activate multiple signaling pathways including the downstream MyD88-dependent and the MyD88-independent pathways, which regulate the expressions of a variety of inflammatory cytokines and are involved in inflammation and immune responses (6).

The present study was designed to analyze the immune mechanisms of intestinal TLRs and the MAPK signaling pathway after severe HFMD EV71 infection.

Subjects and methods

Subject information

A total of 86 children admitted to the Xuzhou Children's Hospital (Jiangsu, China) from January 2013 to January 2016 with a throat-swab-pathologic-examination-confirmed diagnosis of EV71 HFMD for the first time were contiguously enrolled in the study. A total of 49 children had a mild disease and 27 children a severe form of the disease. The mild disease group included 29 boys and 20 girls, with a mean age of 4.5±0.6 years; the severe disease group included 17 boys and 10 girls with a mean age of 4.9±0.8 years. In addition, 30 healthy children were enrolled in a control group, including 18 boys and 12 girls with a mean age of 4.8±0.7 years. Comparisons of general information between the three groups yielded no significant differences.

Study methods

Under fasting conditions, 6 ml elbow venous blood samples were collected from each patient, and 2 ml was used for separating peripheral blood mononuclear cells (PBMC) and testing for TLRs, 2 ml for immune cytokine testing, and 2 ml for MAPK signaling pathways testing.

Quantification of TLR and MAPK signaling molecule mRNA expression

Lymphocyte separation medium was added to peripheral blood samples and these were then centrifuged. The suspended PBMC were isolated in Eppendorf tubes. For RNA extraction, 1 ml TRIzol lysis buffer (Invitrogen Life Technologies, Carlsbad, CA, USA) was added, and the closed tubes were inverted until well mixed, chloroform and isopropanol were then added before centrifugation. The pellets of RNA were washed twice with ethanol; and after the last concentration, purity and integrity were tested. Good quality RNA samples were inversely transcribed into cDNA with first-strand cDNA synthesis kit (Promega Corp., Madison, WI, USA), the experiments were carried out according to the fluorescence quantitative PCR kit instructions. Specific fragments from TLR2, 3, 4, 7, 8 and 9 as well as ERK, JNK and p38 mRNA were amplified, mRNA levels of each target gene were calculated normalizing against GAPDH RNA levels (internal reference).

Testing of cytokine levels in the serum

Peripheral blood samples were centrifuged at 2,000 × g for 20 min, the upper serum layer was used in an enzyme-linked immunosorbent assay (ELISA). Briefly, an ELISA kit was used to test the tumor necrosis factor (TNF)-α, interferon (IFN)-γ, interleukin (IL)-6 and IL-10 levels in the serum samples, the kit was purchased from the Sigma (St. Louis, MO, USA), and a microplate reader was purchased from Beijing Liuyi Instrument Factory (Beijing, China), and carried out according to the manufacturer's instructions.

Statistical analysis

The SPSS 20.0 software (IBM SPSS, Armonk, NY, USA) was used for data entry and processing. Measurement data were expressed as mean ± standard deviation, comparisons among groups were analyzed with a one-way ANOVA method, and pairwise comparisons were tested with an LSD-t-test method. Countable data were expressed as rates and the comparisons among groups were analyzed with a χ2 test. Finally, a Pearson correlation analysis of measurement data was done after a normality test. P<0.05 was considered to indicate a statistically significant difference.

Results

Comparison of the expression levels of TLR mRNAs among the groups

The average expression levels of TLR3, TLR4, TLR7 and TLR8 mRNAs in the isolated PBMCs of subjects in the three groups were significantly different (P<0.05), and those of TLR2 and TLR9 mRNAs were not (P>0.05). The average expression levels of TLR3, TLR4, TLR7 and TLR8 mRNAs in PBMCs of the severe disease group were significantly higher than those in the other two groups, with the lowest values being found in the control group (P<0.05; Table I).

Table I.

Comparison of the expression levels of TLR mRNAs in PBMCs of subjects in the three groups.

Table I.

Comparison of the expression levels of TLR mRNAs in PBMCs of subjects in the three groups.

GroupsTLR2TLR3TLR4TLR7TLR8TLR9
Control1.00±0.161.00±0.131.00±0.091.00±0.191.00±0.151.00±0.11
Mild disease1.05±0.14 1.89±0.26a 1.91±0.24a 1.77±0.20a 1.58±0.23a1.08±0.15
Severe disease1.09±0.12 3.32±0.48a,b 3.88±0.59a,b 3.27±0.41a,b 3.06±0.52a,b0.92±0.12

a There were significant differences in the comparison with the control group, P<0.05

b there were significant differences in the comparison with the mild disease group, P<0.05. TLR, Toll-like receptor; PBMCs, peripheral blood mononuclear cells.

Comparison of expression levels of cytokines in the serum

The average expression levels of TNF-α, IFN-γ, IL-6 and IL-10 in the serum of subjects in the three groups were significantly different. Average expression levels of TNF-α, IFN-γ, IL-6 and IL-10 in the serum of the severe disease group were higher than those in the other two groups, the lowest values were found in the control group (P<0.05; Table II).

Table II.

Comparison of expression levels of cytokines in serum of subjects in the three groups.

Table II.

Comparison of expression levels of cytokines in serum of subjects in the three groups.

GroupsTNF-α, ng/mlIFN-γ, pg/mlIL-6, ng/mlIL-10, pg/ml
Control11.48±1.86   7.68±0.92   23.58±5.86   9.14±0.15
Mild disease 18.59±2.49a 18.51±2.64a   47.64±7.12a 17.79±2.52a
Severe disease 55.75±8.64a,b 30.24±5.42a,b 142.86±25.38a,b 28.58±4.82a,b

a There were significant differences in the comparison with the control group, P<0.05

b there were significant differences in the comparison with the mild disease group, P<0.05. TNF, tumor necrosis factor; IFN, interferon; IL, interleukin.

Correlation between TLR levels in PBMCs and cytokine levels in serum

Pearson correlation analysis showed that the TLR3, TLR4, TLR7 and TLR8 mRNA levels in PBMCs were positively correlated with TNF-α, IFN-γ, IL-6 and IL-10 levels in the serum (P<0.05; Table III).

Table III.

Correlation between TLR mRNA levels in PBMCs and cytokine levels in serum.

Table III.

Correlation between TLR mRNA levels in PBMCs and cytokine levels in serum.

TLR3TLR4TLR7TLR8




t-testP-valuet-testP-valuet-testP-valuet-testP-value
TNF-α0.2840.0350.3010.0300.3460.0230.3480.022
IFN-γ0.3150.0320.2810.0260.3480.0220.3100.024
IL-60.3020.0330.2680.0280.3280.0250.3670.018
IL-100.3250.0300.2960.0250.3030.0280.3490.015

[i] TLR, Toll-like receptor; PBMCs, peripheral blood mononuclear cells; TNF, tumor necrosis factor; IFN, interferon; IL, interleukin.

Comparison of expression levels of MAPK signaling molecules in PBMCs

The average expression levels of ERK, JNK and p38 mRNA in PBMCs of subjects in the three groups were significantly different (P<0.05). Those of ERK, JNK and p38 mRNA in PBMCs of the children in the severe disease group were significantly higher than those in the other two groups, the lowest values were found in the control group (P<0.05; Table IV).

Table IV.

Comparison of expression levels of MAPK signaling molecules in PBMCs of subjects in the three groups.

Table IV.

Comparison of expression levels of MAPK signaling molecules in PBMCs of subjects in the three groups.

GroupsERKJNKp38
Control1.00±0.181.00±0.141.00±0.17
Mild disease 1.83±0.25a 1.59±0.21a 1.77±0.27a
Severe disease 3.52±0.58a,b 3.28±0.52a,b 2.89±0.39a,b

a There were significant differences in the comparison with the control group, P<0.05

b there were significant differences in the comparison with the mild disease group, P<0.05. PBMCs, peripheral blood mononuclear cells.

Correlation between TLR in PBMCs and MAPK mRNA levels

Pearson correlation analysis showed that the TLR3, TLR4, TLR7 and TLR8 mRNA levels in PBMCs were positively correlated with ERK, JNK and p38 mRNA levels (P<0.05; Table V).

Table V.

Correlation between TLR mRNA levels in PBMCs and MAPK levels.

Table V.

Correlation between TLR mRNA levels in PBMCs and MAPK levels.

TLR3TLR4TLR7TLR8




t-testP-valuet-testP-valuet-testP-valuet-testP-value
ERK0.4850.0160.5120.0140.4820.0160.5090.016
JNK0.4830.0170.4720.0180.5180.0130.5420.012
p380.5270.0120.5420.0100.5090.0150.5670.009

[i] TLR, Toll-like receptor; PBMCs, peripheral blood mononuclear cells.

Discussion

The immune function of organisms are activated after EV71 infection and secreted cytokine levels by a variety of immune cells increase. On the one hand, these changes are involved in the organism immune protection; on the other hand they can also cause immunopathological injury to the organism. The balance of Th1/Th2 cells is an important mechanism regulating immune function. Th1 cells can synthesize TNF-α, IFN-γ and IL-6, which mainly mediate the cell immune response and play a major role in the antiviral process (7). Th2 cells can synthesize IL-10, inhibit excessive activation of Th1 cells, promote the proliferation of B cells and mainly mediate the humoral immune response (8). Studies have confirmed that the functions of Th1 and Th2 cells in children with HFMD are significantly altered and the synthesis and secretion of cytokines are increased (9,10). In our study, it was found that the expression levels of TNF-α, IFN-γ, IL-6 and IL-10 in the serum of children in the severe disease group were significantly higher than those in the mild disease and the control groups. This is consistent with the cited previous study results. The above cytokines synthesized by Th1 and Th2 cells are not only involved in the organism's protective immune response, they simultaneously promote an inflammatory reaction that can cause adverse reactions. In particular, cytokines synthesized by Th1 cells can cause a systemic inflammatory response syndrome (11) when attempting to clear the virus infections, that is why a Th2 cell response antagonizes the excessive inflammatory response in vivo, acting as the organism's own compensatory defense mechanism (12). When the cytokines synthesized by Th1 and Th2 in pediatric patients with HFMD are increased significantly, they cause a strong traumatic response syndrome (13).

Currently, the changes in levels of Th1 and Th2 secretions in pediatric patients with HFMD, and the mechanisms involved in the regulation of the resulting inflammatory cytokine syntheses are not clear. TLRs are considered the most important pattern recognition molecules in vivo, after a viral infection, a conformational change occurs in them, which leads to activation of a signal transduction through the MyD88-dependent and MyD88-independent pathways. An inflammatory response ensues with diverse cytokines regulating the expression of other inflammatory factors. The present study found that the expression levels of the TLR3, TLR4, TLR7 and TLR8 mRNAs in PBMCs of children in the severe disease group were significantly higher than those in the mild disease and the control groups. And that those levels were positively correlated with TNF-α, IFN-γ, IL-6 and IL-10 levels in the serum. It is therefore possible that TLRs regulate the Th1 and Th2 cytokine production in the child patients with HFMD and help regulate the immune response of HFMD (14,15).

Following TLR activation a cascade of events occurs leading especially to MAPK activation. Then, the signaling pathways mediated by the three signal molecules ERK, JNK and p38 activate c-Jun and c-Fos in the nucleus of lymphocytes and start the transcription of a variety of inflammatory factors (16,17). The present study found that the expression levels of ERK, JNK and p38 mRNA in PBMCs of pediatric patients, in the severe disease group, were significantly higher than those in the mild disease group and the control group, and, that the TLR3, TLR4, TLR7 and TLR8 mRNA levels in PBMCs were positively correlated with ERK, JNK and p38 mRNA levels. From these results, it looks as though the high expression levels of TLR3, TLR4, TLR7 and TLR8 in severe EV71 HFMD regulate cytokine expression by the MAPK pathway and the resulting exaggerated response causes a severe and dangerous syndrome. It is possible that an immunological intervention, downregulating the expression of TLRs, may be a new target in the treatment of severe HFMD.

References

1 

Long DL, Zhu SY, Li CZ, Chen CY, Du WT and Wang X: Late-onset nail changes associated with hand, foot, and mouth disease: A clinical analysis of 56 cases. Pediatr Dermatol. 33:424–428. 2016. View Article : Google Scholar : PubMed/NCBI

2 

Kim C, Kang H, Kim DE, Song JH, Choi M, Kang M, Lee K, Kim HS, Shin JS, Jeong H, et al: Antiviral activity of micafungin against enterovirus 71. Virol J. 13:992016. View Article : Google Scholar : PubMed/NCBI

3 

Li S, Cai C, Feng J, Li X, Wang Y, Yang J and Chen Z: Peripheral T lymphocyte subset imbalances in children with enterovirus 71-induced hand, foot and mouth disease. Virus Res. 180:84–91. 2014. View Article : Google Scholar : PubMed/NCBI

4 

Yang J, Yang C, Guo N, Zhu K, Luo K, Zhang N, Zhao H, Cui Y, Chen L, Wang H, et al: Type I interferons triggered through the Toll-like receptor 3-TRIF pathway control coxsackievirus A16 infection in young mice. J Virol. 89:10860–10867. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Hsiao HB, Chou AH, Lin SI, Chen IH, Lien SP, Liu CC, Chong P and Liu SJ: Toll-like receptor 9-mediated protection of enterovirus 71 infection in mice is due to the release of danger-associated molecular patterns. J Virol. 88:11658–11670. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Chi J, He Y, Yu G and Lei L: Role of Toll-like receptor 7 in the production of inflammatory cytokines in EV-A71-infected human Jurkat T cells. Zhonghua Yu Fang Yi Xue Za Zhi. 50:266–269. 2016.(In Chinese). PubMed/NCBI

7 

Dang S, Gao N, Li Y, Li M, Wang X, Jia X, Zhai S, Zhang X, Liu J, Deng H, et al: Dominant CD4-dependent RNA-dependent RNA polymerase-specific T-cell responses in children acutely infected with human enterovirus 71 and healthy adult controls. Immunology. 142:89–100. 2014. View Article : Google Scholar : PubMed/NCBI

8 

Wei R, Xu L, Zhang N, Zhu K, Yang J, Yang C, Deng C, Zhu Z, de Groot AS, Altmeyer R, et al: Elevated antigen-specific Th2 type response is associated with the poor prognosis of hand, foot and mouth disease. Virus Res. 177:62–65. 2013. View Article : Google Scholar : PubMed/NCBI

9 

Tan S, Tan X, Sun X, Lu G, Chen CC, Yan J, Liu J, Xu W and Gao GF: VP2 dominated CD4+ T cell responses against enterovirus 71 and cross-reactivity against coxsackievirus A16 and polioviruses in a healthy population. J Immunol. 191:1637–1647. 2013. View Article : Google Scholar : PubMed/NCBI

10 

Liu L, Zhang Y, Wang J, Zhao H, Jiang L, Che Y, Shi H, Li R, Mo Z, Huang T, et al: Study of the integrated immune response induced by an inactivated EV71 vaccine. PLoS One. 8:e544512013. View Article : Google Scholar : PubMed/NCBI

11 

Wei R, Yang C, Zeng M, Terry F, Zhu K, Yang C, Altmeyer R, Martin W, De Groot AS and Leng Q: A dominant EV71-specific CD4+ T cell epitope is highly conserved among human enteroviruses. PLoS One. 7:e519572012. View Article : Google Scholar : PubMed/NCBI

12 

Liang Y, Zhou X, Yang E, Pu J, Che Y, Wang J, Ma N, Liu L, Ding D, Tang D, et al: Analysis of the Th1/Th2 reaction in the immune response induced by EV71 inactivated vaccine in neonatal rhesus monkeys. J Clin Immunol. 32:1048–1058. 2012. View Article : Google Scholar : PubMed/NCBI

13 

Dong C, Liu L, Zhao H, Wang J, Liao Y, Zhang X, Na R, Liang Y, Wang L and Li Q: Immunoprotection elicited by an enterovirus type 71 experimental inactivated vaccine in mice and rhesus monkeys. Vaccine. 29:6269–6275. 2011. View Article : Google Scholar : PubMed/NCBI

14 

Lei X, Sun Z, Liu X, Jin Q, He B and Wang J: Cleavage of the adaptor protein TRIF by enterovirus 71 3C inhibits antiviral responses mediated by Toll-like receptor 3. J Virol. 85:8811–8818. 2011. View Article : Google Scholar : PubMed/NCBI

15 

Zhang J, Wang J, Pang L, Xie G, Welte T, Saxena V, Wicker J, Mann B, Soong L, Barrett A, et al: The co-stimulatory effects of MyD88-dependent Toll-like receptor signaling on activation of murine γδ T cells. PLoS One. 9:e1081562014. View Article : Google Scholar : PubMed/NCBI

16 

Zou J and Shankar N: Roles of TLR/MyD88/MAPK/NF-κB signaling pathways in the regulation of phagocytosis and proinflammatory cytokine expression in response to E. faecalis infection. PLoS One. 10:e01369472015. View Article : Google Scholar : PubMed/NCBI

17 

Choi HG, Kim WS, Back YW, Kim H, Kwon KW, Kim JS, Shin SJ and Kim HJ: Mycobacterium tuberculosis RpfE promotes simultaneous Th1- and Th17-type T-cell immunity via TLR4-dependent maturation of dendritic cells. Eur J Immunol. 45:1957–1971. 2015. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhu L, Li W, Qi G, Liu N, Sheng L, Shang L and Qi B: The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway. Exp Ther Med 13: 2263-2266, 2017.
APA
Zhu, L., Li, W., Qi, G., Liu, N., Sheng, L., Shang, L., & Qi, B. (2017). The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway. Experimental and Therapeutic Medicine, 13, 2263-2266. https://doi.org/10.3892/etm.2017.4245
MLA
Zhu, L., Li, W., Qi, G., Liu, N., Sheng, L., Shang, L., Qi, B."The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway". Experimental and Therapeutic Medicine 13.5 (2017): 2263-2266.
Chicago
Zhu, L., Li, W., Qi, G., Liu, N., Sheng, L., Shang, L., Qi, B."The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway". Experimental and Therapeutic Medicine 13, no. 5 (2017): 2263-2266. https://doi.org/10.3892/etm.2017.4245
Copy and paste a formatted citation
x
Spandidos Publications style
Zhu L, Li W, Qi G, Liu N, Sheng L, Shang L and Qi B: The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway. Exp Ther Med 13: 2263-2266, 2017.
APA
Zhu, L., Li, W., Qi, G., Liu, N., Sheng, L., Shang, L., & Qi, B. (2017). The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway. Experimental and Therapeutic Medicine, 13, 2263-2266. https://doi.org/10.3892/etm.2017.4245
MLA
Zhu, L., Li, W., Qi, G., Liu, N., Sheng, L., Shang, L., Qi, B."The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway". Experimental and Therapeutic Medicine 13.5 (2017): 2263-2266.
Chicago
Zhu, L., Li, W., Qi, G., Liu, N., Sheng, L., Shang, L., Qi, B."The immune mechanism of intestinal tract Toll-like receptor in mediating EV71 virus type severe hand-foot-and-mouth disease and the MAPK pathway". Experimental and Therapeutic Medicine 13, no. 5 (2017): 2263-2266. https://doi.org/10.3892/etm.2017.4245
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team